HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Akassoglou Selected Research

K Akassoglou Research Topics

Disease

4Inflammation (Inflammations)
03/2019 - 10/2000
2Multiple Sclerosis
01/2007 - 10/2000
2Demyelinating Diseases (Demyelinating Disease)
10/2000 - 05/2000
1Neuroinflammatory Diseases
03/2019
1Neurocognitive Disorders (Clerambault Syndrome)
03/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2009
1Rheumatoid Arthritis
01/2007
1Bacterial Infections (Bacterial Infection)
01/2007
1Myocardial Infarction
01/2007
1Rupture
01/2007
1Sepsis (Septicemia)
01/2007
1Atherosclerosis
10/2001
1Central Nervous System Diseases (CNS Diseases)
10/2000
1Necrosis
10/2000

Drug/Important Bio-Agent (IBA)

2Blood Proteins (Serum Proteins)IBA
07/2009 - 01/2007
2Fibrinogen (Factor I)FDA Link
07/2009 - 01/2007
2LigandsIBA
01/2007 - 10/2000
17,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA
03/2019
1LipidsIBA
03/2019
1NexusIBA
01/2007
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2007
1IntegrinsIBA
01/2007
1Biomarkers (Surrogate Marker)IBA
10/2001
1Plasminogen Activators (Plasminogen Activator)IBA
10/2001
1Lymphotoxin-alpha (Lymphotoxin)IBA
10/2000
1Type I Tumor Necrosis Factor ReceptorsIBA
10/2000
1Type II Tumor Necrosis Factor ReceptorsIBA
10/2000
1PlasminogenIBA
05/2000
1Tissue Plasminogen Activator (Alteplase)FDA Link
05/2000

Therapy/Procedure

1Investigational Therapies (Experimental Therapy)
10/2000